Increased inflammatory signature in myeloid cells of non-small cell lung cancer patients with high clonal hematopoiesis burden
2024

Inflammation in Lung Cancer Patients with Clonal Hematopoiesis

Sample size: 100 publication 10 minutes Evidence: moderate

Author Information

Author(s): Sim Hyungtai, Park Hyun Jung, Park Geun-Ho, Kim Yeon Jeong, Park Woong-Yang, Lee Se-Hoon, Choi Murim

Primary Institution: Seoul National University College of Medicine

Hypothesis

What is the impact of clonal hematopoiesis on the response to immunotherapy in non-small cell lung cancer patients?

Conclusion

Clonal hematopoiesis prevalence is higher in lung cancer patients, particularly in squamous cell carcinoma, but it has minimal impact on immunotherapy response.

Supporting Evidence

  • Clonal hematopoiesis was found in 44 out of 100 lung cancer patients compared to 5 out of 42 controls.
  • Lung squamous cell carcinoma patients had a higher burden of larger clones compared to lung adenocarcinoma patients.
  • Single-cell RNA sequencing revealed significant enrichment of inflammatory pathways in myeloid cells of patients with high clonal hematopoiesis.

Takeaway

This study found that many lung cancer patients have a specific blood condition called clonal hematopoiesis, which is linked to inflammation but doesn't really change how well their treatment works.

Methodology

Blood samples were collected from 100 metastatic NSCLC patients for sequencing and analysis of clonal hematopoiesis and single-cell RNA sequencing.

Potential Biases

The cohort was biased towards older ages and higher smoking prevalence, which are known factors affecting clonal hematopoiesis.

Limitations

The study cohort had differences in age and smoking status compared to controls, which may confound results.

Participant Demographics

100 metastatic NSCLC patients, with a higher prevalence of smoking and older age compared to controls.

Statistical Information

P-Value

0.01

Statistical Significance

p = 0.01

Digital Object Identifier (DOI)

10.7554/eLife.96951

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication